The Immune Phenotype of Isolated Lymphoid Structures in Non-Tumorous Colon Mucosa Encrypts the Information on Pathobiology of Metastatic Colorectal Cancer
Authors:
- Felicitas MungenastFMFelicitas Mungenast
- Anastasia MeshcheryakovaAMAnastasia Meshcheryakova
- Andrea BeerABAndrea Beer
- Martina SalzmannMSMartina Salzmann
- Dietmar TamandlDTDietmar Tamandl
- Thomas GruenbergerTGThomas Gruenberger
- Peter PietschmannPPPeter Pietschmann
- Oskar KoperekOKOskar Koperek
- Peter BirnerPBPeter Birner
- Ilan KirschIKIlan Kirsch
- Harlan RobinsHRHarlan Robins
- Martina MittlboeckMMMartina Mittlboeck
Open Access
Abstract
The gut-associated lymphoid tissue represents an integral part of the immune system. Among the powerful players of the mucosa-associated lymphoid tissue are isolated lymphoid structures (ILSs), which as information centers, drive the local (and systemic) adaptive immune responses. Germinal center reactions, taking place within ILSs, involve the coordinated action of various immune cell types with a central role given to B cells. In the current study, we aimed at dissecting the impact of ILSs within non-tumorous colon tissue (NT) on the pathobiology of colorectal cancer (CRC) with metastasis in the liver (CRCLM). In particular, we focused on the immune phenotypes of ILSs and ectopic lymphoid structures (ELSs), built up at matching primary and metastatic tumor sites. We implemented an integrative analysis strategy on the basis of tissue image cytometry and clonality assessment to explore the immune phenotype of ILS/ELS at three tissue entities: NT, CRC, and CRCLM (69 specimens in total). Applying a panel of lineage markers used for immunostaining, we characterized and compared the anatomical features, the cellular composition, the activation, and proliferation status of ILSs and ELSs, and assessed the clinical relevance of staining-derived data sets. Our major discovery was that ILS characteristics at the NT site predefine the immune phenotype of ELSs at CRC and CRCLM. Thereby, B-cell-enriched (CD20) and highly proliferative (Ki67) ILSs and ELSs were found to be associated with improved clinical outcome in terms of survival and enabled patient stratification into risk groups. Moreover, the data revealed a linkage between B-cell clonality at the NT site and the metastatic characteristics of the tumor in the distant liver tissue. Consolidation of immunostaining-based findings with the results of compendium-wide transcriptomic analysis furthermore proposed CD27 as a novel marker of T follicular helper cells within lymphoid structures. Overall, the study nominates the ILS immune phenotype as a novel prognostic marker for patients with metastatic CRC.Keywords
Funding Information
- Oesterreichische Nationalbank (Nr. 17278 to DM)
This publication has 56 references indexed in Scilit:
- Tumor-infiltrating B cellsOncoImmunology, 2012
- 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?Scientific Reports, 2012
- Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancerCancer Immunology, Immunotherapy, 2012
- Isolated Lymphoid Follicles are Dynamic Reservoirs for the Induction of Intestinal IgAFrontiers in Immunology, 2012
- Activation-Induced Cytidine Deaminase (AID)-Associated Multigene Signature to Assess Impact of AID in Etiology of Diseases with Inflammatory ComponentPLOS ONE, 2011
- Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array ProfilingThe American Journal of Pathology, 2011
- The Relationship between CD27 Negative and Positive B Cell Populations in Human Peripheral BloodFrontiers in Immunology, 2011
- Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodulesClinical and Experimental Immunology, 2010
- Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid StructuresJournal of Clinical Oncology, 2008
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004